Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CyBorD in Newly Diagnosed Multiple Myeloma
NCT00609167Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- Dec 2006
- Primary completion
- Jan 2009
- Modality
- Small Molecules, Modified Peptides
- Countries
- 2
01
Overview
A Phase 2 trial of bortezomib in multiple myeloma (MM), sponsored by Mayo Clinic. Started Dec 2006; status: completed.
02
Drugs
bortezomib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00609167.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00609167.